Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · IEX Real-Time Price · USD

3.170

+0.230 (7.82%)

At close: Jul 2, 2024, 4:00 PM

3.090

-0.080 (-2.52%)

After-hours: Jul 2, 2024, 4:24 PM EDT

Tenax Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2001
Market Capitalization	6	7	5	26	23	10	Upgrade
Market Cap Growth	-20.28%	31.60%	-81.01%	11.69%	146.92%	436.08%	Upgrade
Enterprise Value	-6	-3	4	21	17	4	Upgrade
PE Ratio	-	-0.85	-0.45	-0.81	-2.38	-1.13	Upgrade
PB Ratio	0.50	0.81	3.34	6.18	5.07	2.52	Upgrade
P/FCF Ratio	-0.89	-1.11	-0.44	-2.41	-2.53	-1.26	Upgrade
P/OCF Ratio	-0.89	-1.11	-0.44	-2.41	-2.53	-1.26	Upgrade
EV/EBITDA Ratio	0.38	0.36	-0.32	-0.64	-1.75	-0.50	Upgrade
EV/EBIT Ratio	0.38	0.36	-0.32	-0.64	-1.73	-0.50	Upgrade
EV/FCF Ratio	0.41	0.46	-0.31	-1.92	-1.83	-0.55	Upgrade
Debt / Equity Ratio	0.03	0.06	0.46	0.04	0.05	0.02	Upgrade
Debt / EBITDA Ratio	-0.04	-0.07	-0.06	-0.01	-0.03	-0.01	Upgrade
Debt / FCF Ratio	-0.04	-0.08	-0.06	-0.02	-0.03	-0.01	Upgrade
Quick Ratio	6.18	2.73	1.15	3.57	3.17	2.13	Upgrade
Current Ratio	7.12	3.26	1.74	3.64	3.21	2.44	Upgrade
Interest Coverage	-410.02	-320.72	-2485.58	-34218.56	-6053.94	-	Upgrade
Return on Equity (ROE)	-89.70%	-65.80%	-319.40%	-809.30%	-213.30%	-114.70%	Upgrade
Return on Assets (ROA)	-77.60%	-58.30%	-218.40%	-581.20%	-145.00%	-95.20%	Upgrade
Return on Capital (ROIC)	-82.56%	-95.75%	-506.71%	-739.08%	-202.62%	-223.21%	Upgrade
Earnings Yield	-162.75%	-117.67%	-221.88%	-123.88%	-41.97%	-88.31%	Upgrade
FCF Yield	-150.50%	-90.05%	-228.77%	-41.43%	-39.52%	-79.53%	Upgrade
Buyback Yield / Dilution	-948.64%	-1250.92%	-43.00%	-98.50%	-67.33%	-295.91%	Upgrade
Total Shareholder Return	-948.64%	-1250.92%	-43.00%	-98.50%	-67.33%	-295.91%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).